Metabolic Syndrome and Risk of Cardiovascular Diseases in Female Breast Cancer Survivors
International Journal of Cardiovascular Sciences, ISSN: 2359-5647, Vol: 34, Issue: 4, Page: 420-430
2021
- 7Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Captures7
- Readers7
Article Description
Background: The implementation of intensive therapy protocols increases the probability of adverse events in patients with breast cancer (BC). Components of metabolic syndrome (MS) are among these events. Objective: To verify the prevalence of MS and cardiovascular disease (CVD) risk in female BC survivors. Materials and Methods: This is a descriptive, observational, cross-sectional study. Our sample comprised 60 women without BC (G1) and 60 women who had survived BC (G2). We collected sociodemographic, anthropometric, tumor, and clinical data. After variable analysis, the participants received positive or negative MS diagnoses and a 10-year CVD risk stratification. The significance level adopted for the analyses was 5% (p < 0.05) and the confidence interval (CI) was 95%. For comparing categorical data, we used the chi-squared, Fisher’s exact, or G tests; for comparing continuous data, we used the parametric Student’s t-test and the non-parametric Mann-Whitney test. Results: Both groups presented overweight and an increased waist-to-hip ratio. Weight, body mass index, abdominal circumference, hip circumference, and low-density cholesterol were variables that presented statistically significant differences between groups. MS was diagnosed in 32% of women in G1 and 45% of those in G2. Regarding the 10-year risk for CVD, most women were in the low-risk stratum: the mean total risk of CVD occurrences was 7.48% in G1 and 7.70% in G2. Conclusion: We observed a higher prevalence of MS among women who survived BC, possibly due to overweight, as well as a low 10-year risk for CVD after cancer treatment. Although we did not observe a statistically significant difference, we suggest the adoption of a healthy lifestyle and rigorous control of cardiometabolic risk factors.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85168840127&origin=inward; http://dx.doi.org/10.36660/ijcs.20200411; https://ijcscardiol.org/article/metabolic-syndrome-and-risk-of-cardiovascular-diseases-in-female-breast-cancer-survivors/; http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-56472021005008206&lng=en&tlng=en; http://www.scielo.br/scielo.php?script=sci_abstract&pid=S2359-56472021005008206&lng=en&tlng=en; http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-56472021005008206; http://www.scielo.br/scielo.php?script=sci_abstract&pid=S2359-56472021005008206; http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-56472021000400420&lng=en&tlng=en; http://www.scielo.br/scielo.php?script=sci_abstract&pid=S2359-56472021000400420&lng=en&tlng=en; http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-56472021000400420; http://www.scielo.br/scielo.php?script=sci_abstract&pid=S2359-56472021000400420; https://dx.doi.org/10.36660/ijcs.20200411
Sociedade Brasileira de Cardiologia
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know